Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CTVNASDAQ:DHNASDAQ:MTLSNASDAQ:YXT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCTVInnovid$3.14$3.11$1.50▼$3.40$466.21M3.251.03 million shsN/ADHDefinitive Healthcare$2.75-0.7%$4.41$2.58▼$8.36$310.51M1.51986,235 shs707,863 shsMTLSMaterialise$4.97-0.2%$7.40$4.70▼$9.69$293.56M1.29330,768 shs224,806 shsYXTYXT.COM Group$0.89+2.8%$1.76$0.83▼$11.00$52.27MN/A46,415 shs12,523 shs20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCTVInnovid0.00%0.00%-0.16%+2.61%+64.40%DHDefinitive Healthcare-0.72%-0.72%-48.60%-38.89%-66.55%MTLSMaterialise-0.20%-2.93%-43.84%-41.11%-3.12%YXTYXT.COM Group+0.26%-42.19%-45.13%-58.60%+89,429,900.00%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCTVInnovid0.3962 of 5 stars1.03.00.00.01.40.00.6DHDefinitive Healthcare2.0113 of 5 stars3.02.00.00.01.92.50.6MTLSMaterialise2.5318 of 5 stars3.53.00.00.02.60.01.3YXTYXT.COM GroupN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCTVInnovid 2.00Hold$2.83-9.77% DownsideDHDefinitive Healthcare 2.08Hold$5.3594.55% UpsideMTLSMaterialise 3.00Buy$9.5091.15% UpsideYXTYXT.COM Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest YXT, CTV, DH, and MTLS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/4/2025DHDefinitive HealthcareThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$4.50 ➝ $3.003/3/2025DHDefinitive HealthcareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetUnderweight ➝ Underweight$4.00 ➝ $3.001/16/2025DHDefinitive HealthcareNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold1/13/2025DHDefinitive HealthcareBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingEqual Weight ➝ Underweight$4.00 ➝ $4.0012/20/2024DHDefinitive HealthcareStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageEqual Weight$5.00(Data available from 3/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCTVInnovid$151.56M3.08$0.05 per share62.93$1.39 per share2.26DHDefinitive Healthcare$252.20M1.23$1.65 per share1.67$10.31 per share0.27MTLSMaterialise$266.77M1.10$0.50 per share10.00$4.34 per share1.15YXTYXT.COM Group$336.91M0.16N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCTVInnovid-$31.91M-$0.09N/A78.50N/A-9.09%-7.08%-5.70%N/ADHDefinitive Healthcare-$202.39M-$3.52N/A19.644.06-142.38%1.76%1.12%5/6/2025 (Estimated)MTLSMaterialise$7.28M$0.2519.88∞N/A5.04%5.47%3.37%4/24/2025 (Estimated)YXTYXT.COM GroupN/AN/A0.00∞N/AN/AN/AN/AN/ALatest YXT, CTV, DH, and MTLS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/27/2025Q4 2024DHDefinitive Healthcare$0.07$0.03-$0.04-$0.51$60.60 million$62.29 million2/20/2025Q4 2024MTLSMaterialise$0.05$0.05N/A$0.05$71.66 million$68.24 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCTVInnovidN/AN/AN/AN/AN/ADHDefinitive HealthcareN/AN/AN/AN/AN/AMTLSMaterialiseN/AN/AN/AN/AN/AYXTYXT.COM GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCTVInnovidN/A3.523.52DHDefinitive Healthcare0.332.492.49MTLSMaterialise0.101.811.65YXTYXT.COM GroupN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCTVInnovid25.46%DHDefinitive Healthcare98.67%MTLSMaterialise19.30%YXTYXT.COM GroupN/AInsider OwnershipCompanyInsider OwnershipCTVInnovid9.50%DHDefinitive Healthcare14.84%MTLSMaterialise1.23%YXTYXT.COM GroupN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCTVInnovid2,280148.47 million134.37 millionNot OptionableDHDefinitive Healthcare970112.91 million98.38 millionNot OptionableMTLSMaterialise2,33059.07 million58.34 millionOptionableYXTYXT.COM Group74460.08 millionN/AN/AYXT, CTV, DH, and MTLS HeadlinesRecent News About These CompaniesEQS-News: Digital Learning Taking Off: Insights From Digital Enterprise Learning Solutions Provider YXT.com's 2024-2025 Enterprise Learning ReportMarch 4, 2025 | markets.businessinsider.comYXT.COM Group (NASDAQ:YXT) Shares Up 8.5% - Time to Buy?February 27, 2025 | marketbeat.comYXT.com Implements Enterprise-Wide Learning Solution for Fortune 500 Infrastructure Leader, Advancing Digital TransformationJanuary 7, 2025 | globenewswire.comYXT.COM GROUP HOLDING LIMITED: YXT.com Announces Strategic Management ChangesDecember 24, 2024 | finanznachrichten.deYXT.com Drives Digital Transformation for Leading Chinese Automotive BrandDecember 17, 2024 | markets.businessinsider.comYXT.com Reports Improved Margins Amid Revenue DeclineDecember 13, 2024 | tipranks.comYXT.com Chief Resigns; Founder Takes HelmNovember 27, 2024 | marketwatch.comYXT.com Group Holding Limited Reports Financial Results for First Nine Months of 2024November 26, 2024 | quiverquant.comYXT.com Announces Strategic Management ChangesNovember 26, 2024 | globenewswire.comYXT.com Reports Unaudited Financial Results for the First Nine Months of 2024November 26, 2024 | globenewswire.comYXT.com Group Holding Limited to Announce Financial Results for the First Nine Months of 2024 on November 26, 2024November 20, 2024 | globenewswire.comOwning 36% in YXT.COM Group Holding Limited (NASDAQ:YXT) means that insiders are heavily invested in the company's futureNovember 17, 2024 | finance.yahoo.comYXT.com Group Holding Limited Announces Change of AuditorOctober 31, 2024 | globenewswire.comTop 3 Tech Stocks You'll Regret Missing In Q4October 25, 2024 | msn.comWho has Been Alabama's Most Underrated Player? Just a MinuteOctober 12, 2024 | msn.comThailand’s cash handouts made a ‘very good’ month even better for retail conglomerate Berli Jucker’s CEOOctober 12, 2024 | msn.comYXT.com Group Holding Limited Expands Customer Base to Include Over 200 Fortune 500 Companies in China, Reinforcing Its Leadership in Digital Learning SolutionsOctober 10, 2024 | globenewswire.comYXT.Com Group Holding Ltd ADR (YXT)October 2, 2024 | investing.comYxt.Com Group Holding Ltd ADR YXTSeptember 28, 2024 | morningstar.comYxt.Com Group Holding (NASDAQ:YXT) Stock Quotes, Forecast and News SummarySeptember 28, 2024 | benzinga.comTop 5 Tech Stocks That May Rocket Higher This MonthSeptember 25, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesPrice Targets on NVIDIA Rise in Front of EarningsBy Sarah Horvath | February 24, 2025View Price Targets on NVIDIA Rise in Front of EarningsMarch’s Hottest Stocks: 5 Buys to Consider NowBy Thomas Hughes | February 28, 2025View March’s Hottest Stocks: 5 Buys to Consider NowSoundHound AI Stock at a Crossroads—Is a Bottom in Sight?By Thomas Hughes | February 20, 2025View SoundHound AI Stock at a Crossroads—Is a Bottom in Sight?Tariffs Won’t Stop These 3 Stocks From RisingBy Chris Markoch | March 5, 2025View Tariffs Won’t Stop These 3 Stocks From RisingUnitedHealth's RSI Suggests It Is Extremely Oversold By Sam Quirke | February 24, 2025View UnitedHealth's RSI Suggests It Is Extremely Oversold YXT, CTV, DH, and MTLS Company DescriptionsInnovid NYSE:CTV$3.14 0.00 (0.00%) As of 02/21/2025Innovid Corp. operates an independent software platform that provides ad serving, measurement, and creative services. It offers advertising services for the creation, delivery, and measurement of TV ads across connected TV, mobile TV, and desktop TV environments to advertisers, publishers, and media agencies. The company serves consumer packaged goods, pharmaceutical and healthcare, retail, financial services, and automotive and technology industries; third party agencies; and publishers in the United States, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. Innovid Corp. was incorporated in 2007 and is headquartered in New York, New York.Definitive Healthcare NASDAQ:DH$2.75 -0.02 (-0.72%) Closing price 03/12/2025 04:00 PM EasternExtended Trading$2.78 +0.03 (+1.05%) As of 03/12/2025 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution. The company's platform consists of various functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate firms, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. was founded in 2011 and is headquartered in Framingham, Massachusetts.Materialise NASDAQ:MTLS$4.97 -0.01 (-0.20%) Closing price 03/12/2025 04:00 PM EasternExtended Trading$5.09 +0.12 (+2.41%) As of 03/12/2025 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.YXT.COM Group NASDAQ:YXT$0.91 +0.04 (+4.93%) As of 03/12/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.YXT.COM Group Holding Limited, through its subsidiaries, provides digital corporate learning solution in the People's Republic of China. The company offers corporate learning platform, personalized e-learning system, teaching tools, and online courses, as well as offline courses and courseware recording service. It also engages in the technology development; and sale of Software-as-a-Service and content. YXT.COM Group Holding Limited was formerly known as Unicentury Group Holding Limited and changed its name to YXT.COM Group Holding Limited in May 2021. The company was founded in 2011 and is based in Suzhou, the People's Republic of China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ramaco Resources Pins Hopes on Coal's Untapped Potential Beyond a Market Correction, Moves to Make Now NVIDIA Stock Remains Stunningly Undervalued—Here’s Why Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy 3 Stocks Institutions Are Quietly Dumping Marvell’s 40% Drop Presents a Compelling Buying Opportunity These 3 Dividend Stocks Jumped 15% in a Month—More to Come? Why Wayfair Stock May Be a Hidden Gem for Value Investors Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
